THE COURSE OF PREGNANCY IN WOMEN WITH CHRONIC HEPATITIS B AND C
Keywords:
Pregnancy, viral hepatitis.Abstract
The global prevalence of viral hepatitis is very high and seems to be rising over the years. The infection can profoundly affect pregnant women causing significant maternal and perinatal morbidity and mortality with some strains much worse than others.
References
World Health Organization. Global hepatitis report. Geneva: World Health Organization; 2017, doi:http://dx.doi.org/10.1149/2.030203jes 2017 Licence: CC BY-NC-SA 3.0 IGO. 2017.
Hepatitis C Kills More Americans than Any Other Infectious Disease | CDC Online Newsroom | CDC n.d. https://www.cdc.gov/media/releases/2016/ p0504-hepc-mortality.html (accessed November 10, 2020).
WHO. Progress report on HIV, viral hepatitis and sexually transmitted infections. Who; 2019, doi:http://dx.doi.org/10.1017/ CBO9781107415324.004 2019.
Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;(67):1560–99, doi:http://dx.doi. org/10.1002/hep.29800.
World Health Organization [WHO]. Hepatitis B 2020. https://www.who.int/ news-room/fact-sheets/detail/hepatitis-b (accessed September 11, 2020).
Ganem D, Hepadnaviridae Schneider R. The viruses and their replication. Field’s Virol. 2001.
Liang TJ. Hepatitis B: The virus and disease. Hepatology 2009;49:S13, doi: http://dx.doi.org/10.1002/hep.22511.
Gitlin N. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem 1997, doi:http://dx.doi.org/10.1093/clinchem/43.8.1500.
Health england P. Human hepatitis B immunoglobulin specific for hepatitis B post-exposure. 2019 July 2019.
Robinson W. Hepatitis B virus and hepatitis d virus. In principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995.
Prevention of mother-to-Child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. World Health Organization; 2020.
Stevens CE, Beasley RP, Tsui J, Lee W-C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975, doi:http://dx.doi.org/10.1056/ nejm197504102551503.
EASL. European Association for the Study of the Liver (EASL). 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017, doi:http://dx.doi.org/10.1016/j.jhep.2017.03.021.
Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009, doi:http://dx.doi.org/10.1111/j.1478-3231.2008.01933.x.
Sookoian S. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol 2006, doi:http://dx.doi.org/10.1016/s1665-2681(19)32019-8.
Terrault NA, Levy MT, Cheung KW, Jourdain G. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol 2020, doi:http://dx.doi.org/10.1038/s41575 020-00361-w.
Han YT, Sun C, Liu CX, Xie SS, Xiao D, Liu L, et al. Clinical features and outcome of acute hepatitis B in pregnancy. BMC Infect Dis 2014, doi:http://dx.doi.org/ 10.1149/1471-2334-14-368.
Kimmich N, Dutkowski P, Krähenmann F, Müllhaupt B, Zimmermann R, Ochsenbein-Kölble N. Liver transplantation during pregnancy for acute liver failure due to HBV infection: a case report. Case Rep Obstet Gynecol 2013;2013:1–5, doi:http://dx.doi.org/10.1155/2013/356560.
Kushner T, Sarkar M. Chronic hepatitis B in pregnancy. Clin Liver Dis 2018;12:24–8, doi:http://dx.doi.org/10.1002/cld.727.
Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study. Liver Int 2018;38:813–20, doi:http:// dx.doi.org/10.1111/liv.13594.
Tse KY, Lai FH, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005;43:771–5, doi: http://dx.doi.org/10.1016/j.jhep.2005.05.023.
Shaheen AAM, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int 2010;30:275–83, doi:http://dx. doi.org/10.1111/j.1478-3231.2009.02153.x.
Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg positive mothers. J Viral Hepat 2012, doi:http://dx.doi.org/10.1111/j.1365 2523.2011.01455.x.
Liu Y, Wang M, Yao S, Yuan J, Lu J, Li H, et al. Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of hepatitis B virus. Hepatol Res 2016, doi:http://dx. doi.org/10.1111/hepr.12525.
Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009, doi:http://dx.doi.org/10.1111/j.1365-2523.2008.01056.x.
Bethesda M. Drugs and Lactation Database (LactMed) NCBI Bookshelf. A TOXNET Database n.d. https://www.ncbi.nlm.nih.gov/books/NBK501552/ (accessed September 17, 2020).
Visvanathan K, Dusheiko G, Giles M, Wong ML, Phung N, Walker S, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow up: Position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016, doi:http://dx.doi.org/10.1136/gutjnl-2015-310317.
Raghwani J, Rose R, Sheridan I, Lemey P, Suchard MA, Santantonio T, et al. Exceptional heterogeneity in viral evolutionary dynamics characterises chronic hepatitis C virus infection. PLoS Pathog 2016;12:, doi:http://dx.doi. org/10.1371/journal.ppat.1005524.
Farci P, Purcell RH. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 2000;20:.
Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman M, et al. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction 2019, doi:http://dx.doi.org/ 10.1111/add.14393.
Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int 2011;31:1163–70, doi:http://dx.doi.org/10.1111/j.1478 3231.2011.02556.x.
Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011;364:2405–16, doi:http://dx.doi.org/10.1056/ NEJMoa1012542.
Wilson E, Beckmann M. Antenatal screening for hepatitis C: Universal or risk factor based? Aust New Zeal J Obstet Gynaecol 2015;55:318–22, doi:http:// dx.doi.org/10.1111/ajo.12296.
American Association for the study of liver diseases (AASLD). Recommen dations for Testing, Managing, and Treating Hepatitis C | HCV Guidance n.d. https://www.hcvguidelines.org/ (accessed September 18, 2020).
Viral Hepatitis Surveillance Report 2018 — Hepatitis C | CDC n.d. https:// www.cdc.gov/hepatitis/statistics/2018surveillance/HepC.htm#Figure3.1 (accessed November 12, 2020).
Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis 2014, doi:http:// dx.doi.org/10.1093/cid/ciu643.
Patrick SW, Bauer AM, Warren MD, Jones TF, Wester C. Hepatitis C virus infection among women giving birth — tennessee and United States, 2009 2014. MMWR Morb Mortal Wkly Rep 2017;66:470–3, doi:http://dx.doi.org/ 10.15548/mmwr.mm6618a3.
Jaiswal SPB, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynecol Obstet 2001;72:103–8, doi:http://dx.doi.org/ 10.1016/S0020-7255(00)00264-2.
Miriam J, Alter PD, Wendi L, Kuhnert PD, Lyn Finelli DPH. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Natl Cent infect dis. 2003. . (accessed September 18, 2020) https://www.cdc.gov/ mmwr/preview/mmwrhtml/rr5203a1.htm.
Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 2014;59:765–73, doi:http://dx.doi.org/10.1093/cid/ciu447.
Tovo PA, Newell ML, Coll O, de Tejada BM, Lanari M, Bosi I, et al. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus: european Paediatric Hepatitis C Virus Network. Br J Obstet Gynaecol 2001;108:371–7, doi:http://dx.doi.org/ 10.1016/S0306-5456(00)00051-7.
Yoles I, Sheiner E, Abu-Freha N, Wainstock T. Maternal hepatitis B or C status and the long-term risk of gastrointestinal morbidity for offspring: a population-based cohort study. Liver Int 2019;39:2046–51, doi:http://dx. doi.org/10.1111/liv.14193.
Wijarnpreecha K, Thongprayoon C, Sanguankeo A, Upala S, Ungprasert P, Cheungpasitporn W. Hepatitis C infection and intrahepatic cholesta sis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2017;41:39–45, doi:http://dx.doi.org/10.1016/j. clinre.2016.07.004.
Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol 2016;111:176–94, doi:http://dx.doi.org/10.1038/ ajg.2015.430.
Hughes BL, Page CM, Kuller JA. Hepatitis C in pregnancy: screening, treatment, and management. Am J Obstet Gynecol 2017;217:B2–12, doi: http://dx.doi.org/10.1016/j.ajog.2017.07.039.
Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses 2012;4:3531–50, doi: http://dx.doi.org/10.3353/v4123531.
Dunkelberg JC, Berkley EMF, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol 2014, doi: http://dx.doi.org/10.1038/jp.2014.167.
Azzari C, Moriondo M, Indolfi G, Betti L, Gambineri E, De Martino M, et al. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol 2008;80:65–71, doi:http://dx.doi.org/10.1002/jmv.21023.
Kalafateli M, Buzzetti E, Thorburn D, Davidson BR, Tsochatzis E, Gurusamy KS. Pharmacological interventions for acute hepatitis C infection. Cochrane Database Syst Rev 2018;2018:, doi:http://dx.doi.org/10.1002/14651451. CD011644.pub3.
Papatheodoridis GV, Hatzakis A, Cholongitas E, Baptista-Leite R, Baskozos I, Chhatwal J, et al. Hepatitis C: the beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. J Viral Hepat 2018;25:6–17, doi:http://dx.doi.org/10.1111/jvh.12505.
Page CM, Hughes BL, Rhee EHJ, Kuller JA. Hepatitis C in pregnancy: review of current knowledge and updated recommendations for management. Obstet Gynecol Surv 2017, doi:http://dx.doi.org/10.1097/ OGX.0000000000000442.
Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV. Management of acute HCV infection in the era of direct-acting antiviral therapy. Nat Rev Gastroenterol Hepatol 2018, doi:http://dx.doi.org/10.1038/s41575-018 0026-5.
Hajarizadeh B, Cunningham EB, Valerio H, Martinello M, Law M, Janjua NZ, et al. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis. J Hepatol 2020;72:643–57, doi: http://dx.doi.org/10.1016/j.jhep.2019.11.012.
Zanetti AR, Tanzi E, Newell ML. Mother-to-infant transmission of hepatitis C virus. J Hepatol Suppl 1999, doi:http://dx.doi.org/10.1016/s0168-8278(99) 80383-3.
